GHK-Cu (copper peptide) Dosage: What the Evidence Says (2026)
Not FDA-approved
Copper-binding tripeptide used in skin care. Topical studies only; no human injection data.
Also called: copper tripeptide-1, GHK copper
Regulatory status (US)
Not approved as a drug; widely used as a cosmetic ingredient in skin products. Since May 2026 the FDA lists GHK-Cu for non-injectable routes in Category 1, which lets pharmacies compound it while it is evaluated. The injectable form was removed from the "significant safety risk" list in April 2026 but is not in Category 1, and it is not in the October 2026 HHS draft policy.
What it is
A naturally occurring three-amino-acid peptide that binds copper.
Dosage
GHK-Cu reconstitution calculator
Enter your vial and your prescribed dose to see the units on a U-100 syringe.
What human studies show
- Only small topical (skin) studies, for example facial serums applied twice daily.
- No human data for injection (FDA: limited human data).
Safety
- No established injectable human dose.
Questions
- Is GHK-Cu FDA-approved?
- Not approved as a drug; widely used as a cosmetic ingredient in skin products. Since May 2026 the FDA lists GHK-Cu for non-injectable routes in Category 1, which lets pharmacies compound it while it is evaluated. The injectable form was removed from the "significant safety risk" list in April 2026 but is not in Category 1, and it is not in the October 2026 HHS draft policy.
- What dose of GHK-Cu has been studied?
- There is no established human dose. Only small topical (skin) studies, for example facial serums applied twice daily. No human data for injection (FDA: limited human data).
- How many units is my GHK-Cu dose?
- Divide the mg in the vial by the mL of bacteriostatic water to get mg/mL, divide your dose in mg by that, and multiply by 100 for units on a U-100 syringe. The calculator on this page does it and draws the syringe.
Related
The first 29 amino acids of GHRH. Former brand Geref was withdrawn in 2009; no product is marketed today.
BPC-15715-amino-acid peptide studied mostly in animals. Not approved; no established human dose.
TB-500 (thymosin beta-4)Name used for thymosin beta-4 and for a 7-amino-acid fragment of it. Not approved; no human dose data for the fragment.
KLOW and GLOW blendsSeller-defined mixes of GHK-Cu, BPC-157, TB-500 (GLOW) plus KPV (KLOW). No human data for any blend.
Sources
- FDA: 503A bulk drug substance categories (updated May 14, 2026, PDF)
- Federal Register (public inspection) 2026-07361: peptide category changes
- Pickart & Margolina 2018: Regenerative and protective actions of the GHK-Cu peptide (review)
- FDA 510(k) K212499: BD insulin syringes for U-100 insulin
Last checked 2026-11-16. How we pick and check sources: methodology.